VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET ANALYSIS | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• VIRAL VECTOR AND PLASMID DNA TESTING SERVICES
  MARKET ANALYSIS
• Viral Vector and Plasmid DNA Testing Services
  Market, by Testing Services (Safety, Genetic
  Characterization, Purity, Identity, and Potency),
  by End User (Research Organizations and
  Pharmaceutical and Biotechnological Companies),
  and by Region (North America, Latin America,
  Europe, Asia Pacific, Middle East, and Africa) -
  Size, Share, Outlook, and Opportunity Analysis,
  2019 - 2027

3

• Viral vectors are widely used in gene therapies.
  The viral vectors are majorly used by researchers
  to deliver genetic materials in the cells. Viral
  vectors are playing significant role in the
  pharmaceutical sector, as many research and
  innovations are ongoing for the development of
  drugs for treating cancer, cardiovascular
  diseases, ophthalmology, hematology, and many
  others.
• Market players are focusing on partnership to
  expand their business in the viral vector and
  plasmid DNA testing services market, which is
  expected to boost growth of the market over the
  forecast period. For instance, in November 2019,
  Harvard University and Massachusetts Institute of
  Technology entered into a partnership with GE
  Healthcare Life Sciences, Fujifilm, and five
  research hospitals, in order to build a research
  center worth US 50 million at Greater Boston,
  U.S. for developing new cell and gene therapy.
  The hospitals involved in the partnership include
  Beth Israel Deaconess Medical Center, Boston
  Childrens Hospital, Brigham and Womens
  Hospital, the Dana-Farber Cancer Institute, and
  Massachusetts General Hospital.

4

• Figure 1. Global Viral Vector and Plasmid DNA
  Testing Services Market Value (US Mn), by
  Region, 2018

5

• Inorganic growth strategies such as business
  expansions adopted by key players is expected to
  boost growth of the global viral vector and
  plasmid DNA testing services market.
• The global viral vector and plasmid DNA testing
  services market is expected to witness
  significant growth over the forecast period,
  owing to business expansions by key players. For
  instance, in May 2016, Eurofins MWG Operon LLC.,
  a subsidary of Eurofins Scientific Company,
  announced to open a new DNA sequencing Lab in
  Toronto, Canada, in order to offer sequencing
  services using Sanger method to researchers in
  Canada.

6
Increasing acquisitions by key players for better
penetration in the market is expected to drive
the market growth.

• North America is expected to hold a dominant
  position in the global viral vector and plasmid
  DNA testing services market, owing to increasing
  acquisition by key players, which is expected to
  drive the North America market growth over the
  forecast period. For instance, in September 2016,
  Charles River Laboratories, Inc. acquired Agilux
  Laboratories, Inc. for around US 62.0 million.
  The acquisition strengthened Charles River
  Laboratories, Inc.s offering for clients drug
  research process.
• Moreover, Europe is expected to be the second
  dominating region in the global viral vector and
  plasmid DNA testing services market over the
  forecast period, owing to acquisitions by key
  players in the region. For instance, in 2017
  Eurofins Scientific acquired Amatsigroup, a CDMO
  offering preclinical and clinical phase services
  for the development of human and veterinary
  drugs. The acquisition is expected to strengthen
  Eurofins position in its BioPharma services
  business.

7
Key Players

• Major players operating in the global viral
  vector and plasmid DNA testing services market
  include Charles River Laboratories, Inc., WuXi
  AppTec Co., Ltd., Cobra Biologics and
  Pharmaceutical Services, Merck KGaA, Lonza,
  Eurofins Scientific, FinVector Vision Therapies,
  Advanced Bioscience Laboratories, Inc., Takara
  Bio Inc., ViruSure GmbH, and Genezen Laboratories
  among others.

8

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/viral-vector-and-plasmid-dna-testin
  g-services-market-3637

9
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

10
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

11
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/